Status:
COMPLETED
Plasma Oxalate in Patient With Short Bowel
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Short Bowel Syndrome
Hyperoxaluria
Eligibility:
All Genders
18+ years
Brief Summary
Hyperoxaluria due to fat malabsorption is seen in patients suffering from short bowel and can lead to stones and nephrocalcinosis. Not all patients are prone to these renal complications. only urinary...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Type II short bowel for more than 6 months
- Affiliated to a social health care
Exclusion
- Primary hyperoxaluria
- Other type of short bowel than type II
- Minor patient or major patient protected by the law
Key Trial Info
Start Date :
February 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 4 2022
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT04119765
Start Date
February 27 2020
End Date
May 4 2022
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nephrology Department, Edouard Herriot Hospital
Lyon, France, 69003